First report of Tsukamurella endocarditis in an immunocompromised patient receiving chemotherapy

Tsukamurella spp. are gram-positive rods that can be isolated from the environment in soil and moist areas. In rare instances, they are known to cause infections in immunocompromised hosts. We present the first reported case of Tsukamurella endocarditis in an immunocompromised patient who was succes...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of clinical microbiology & infectious diseases 2020-10, Vol.39 (10), p.1989-1991
Hauptverfasser:	Malik, Zain, Shah, Punit J., Tariq, Farheen
Format:	Artikel
Sprache:	eng
Schlagworte:	Actinobacteria - genetics Actinobacteria - isolation & purification Anti-Bacterial Agents - administration & dosage Anti-Bacterial Agents - therapeutic use Antineoplastic Agents - therapeutic use Biomedical and Life Sciences Biomedicine Brief Report Chemotherapy Diagnosis, Differential Endocarditis Endocarditis, Bacterial - diagnosis Endocarditis, Bacterial - drug therapy Endocarditis, Bacterial - microbiology Female Humans Imipenem Imipenem - administration & dosage Imipenem - therapeutic use Immunocompromised Host Immunocompromised hosts Infectious Diseases Internal Medicine Life Sciences & Biomedicine Lung Neoplasms - drug therapy Medical Microbiology Microbiology Middle Aged Science & Technology Small Cell Lung Carcinoma - drug therapy Soil moisture Sulfamethoxazole Trimethoprim Trimethoprim, Sulfamethoxazole Drug Combination - administration & dosage Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use Trimethoprim-sulfamethoxazole
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Tsukamurella spp. are gram-positive rods that can be isolated from the environment in soil and moist areas. In rare instances, they are known to cause infections in immunocompromised hosts. We present the first reported case of Tsukamurella endocarditis in an immunocompromised patient who was successfully treated with a 6-week course of imipenem and trimethoprim-sulfamethoxazole.
ISSN:	0934-9723 1435-4373
DOI:	10.1007/s10096-020-03917-5